2014 - Stephen T. Oh, MD, PhD
Doris Duke-Damon Runyon Clinical Investigator
"Targeting aberrant signaling pathways in myeloproliferative neoplasms" with Daniel C. Link, MD, at Washington University, St. Louis, Missouri
2012 - Oren J. Becher, MD
"Regional differences in central nervous system gliomagenesis" with Darell D. Bigner, MD, PhD, and Katherine E. Warren, MD at Duke University, Durham, North Carolina
2010 - Tobias J.E. Carling, MD, PhD
Doris Duke-Damon Runyon Clinical Investigator
"Molecular genetics of endocrine tumor disease" with Richard P. Lifton, MD, PhD, and Robert Udelsman, MD, MBA, at the Yale University School of Medicine, New Haven, Connecticut
2005 - Phillip Febbo
"Mechanisms of Docetaxel Resistance in Hormone Refractory Prostate Center"
2004 - Jeremy Rich, M.D.
Maximizing clinical efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in glioblastoma therapy
To be considered for nomination, the following should be submitted in one PDF to Dena Buchanan at dena.buchanan@duke.edu by Wednesday , December 16th 2020. The DCI’s Scientific Review Committee will review all internal applications and select their nominations no later than Monday, January 4, 2021.
- Applicant’s NIH biosketch
- Mentor’s NIH biosketch
- 2 pages including the following:
- Applicant’s eligibility
- Outline of the position of the applicant and mentor
- Summary of the mentor’s training record for the past 10 years
- Brief description of the research proposal
- Budget and budget justification
Those selected as nominees will then follow the application instructions (provided in the link below) to submit a full application.
The 2021 application deadline is Monday, February 1, 2021. For detailed information about the award, eligibility criteria, application guidelines and forms, please visit the below link.
https://www.damonrunyon.org/for-scientists/application-guidelines/clinical-investigator